Drug intelligence / Profile preview

RHN001-Dx

Development stage: Unknown
Lead developer: Rhine Pharma
Modality: Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration: Intravenous

Overview

RHN001-Dx is a prostate-specific membrane antigen (PSMA)-targeting small molecule radiopharmaceutical developed by Rhine Pharma, a subsidiary of Telix Pharmaceuticals. Labeled with the radioisotope technetium-99m (99mTc), it is designed for single-photon emission computed tomography (SPECT) imaging of PSMA-expressing lesions in patients with prostate cancer. The compound is derived from PSMA-GCK01 and is currently being evaluated in the Phase 1/2 RHINO clinical trial in South Africa to assess its safety and efficacy in detecting advanced prostate cancer. RHN001-Dx forms a theranostic pair with RHN001-Tx, which utilizes the same targeting molecule labeled with rhenium-188 for radioligand therapy.

Other names: 99mTc-PSMATechnetium-99m PSMA diagnostic agentTechnetium99m PSMA diagnostic agentTechnetium 99m PSMA diagnostic agent

Targets

PSMA (Prostate-specific membrane antigen)

Beyond the preview

Go deeper on RHN001-Dx.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RHN001-Dx.

Explore the full profile